Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Recursion Pharmaceuticals Inc RXRX

Healthcare Biotechnology
Recursion Pharmaceuticals, Inc. is a clinical-stage TechBio company decoding biology to industrialize drug discovery. Its Recursion Operating System (OS), a platform built across diverse technologies, enables the Company to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe. The Company integrates physical and digital components as iterative... see more

Recent & Breaking News (NDAQ:RXRX)

Altitude Lab Startups Raise Over $120M in Capital

GlobeNewswire January 24, 2024

Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference

GlobeNewswire January 8, 2024

Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline

GlobeNewswire January 4, 2024

Recursion to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8

GlobeNewswire January 3, 2024

Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry

GlobeNewswire December 20, 2023

Bayer and Recursion Focus Research Collaboration on Oncology

GlobeNewswire November 9, 2023

Recursion Announces Data Collaboration Deal with Tempus, Top 50 Supercomputer Ambition Powered by NVIDIA, and Updated Focus of Collaboration with Bayer to Precision Oncology

GlobeNewswire November 9, 2023

Recursion Provides Business Updates and Reports Third Quarter 2023 Financial Results

GlobeNewswire November 9, 2023

Recursion to Participate in Upcoming Investor Conference

GlobeNewswire November 2, 2023

Recursion to Participate in Upcoming Investor Conferences

GlobeNewswire September 5, 2023

Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection

GlobeNewswire September 5, 2023

Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds

GlobeNewswire August 8, 2023

Recursion Provides Business Updates and Reports Second Quarter 2023 Financial Results

GlobeNewswire August 8, 2023

Recursion to Participate in Upcoming Investor Conference

GlobeNewswire August 1, 2023

Recursion Launches Valence Labs at ICML with a Commitment to Open Science Including $1 Million in Academic Scholarships

GlobeNewswire July 26, 2023

Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery

GlobeNewswire July 12, 2023

Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem

GlobeNewswire June 26, 2023

Recursion's Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation has Fully Enrolled

GlobeNewswire June 13, 2023

Recursion to Participate in Upcoming Investor Conferences

GlobeNewswire June 1, 2023

Altitude Lab Relocates to Gateway's BioHive Hub

GlobeNewswire May 25, 2023